Eurofins Scientific Se Stock Shares Owned By Insiders
| ERFSF Stock | USD 48.45 0.91 1.91% |
Eurofins Scientific SE fundamentals help investors to digest information that contributes to Eurofins Scientific's financial success or failures. It also enables traders to predict the movement of Eurofins Pink Sheet. The fundamental analysis module provides a way to measure Eurofins Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eurofins Scientific pink sheet.
Eurofins |
Eurofins Scientific SE Company Shares Owned By Insiders Analysis
Eurofins Scientific's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Eurofins Scientific Shares Owned By Insiders | 32.76 % |
Most of Eurofins Scientific's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eurofins Scientific SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 32.76% of Eurofins Scientific SE are shares owned by insiders. This is 115.81% higher than that of the Healthcare sector and 113.0% higher than that of the Diagnostics & Research industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Eurofins Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eurofins Scientific's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Eurofins Scientific could also be used in its relative valuation, which is a method of valuing Eurofins Scientific by comparing valuation metrics of similar companies.Eurofins Scientific is currently under evaluation in shares owned by insiders category among its peers.
Eurofins Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.075 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 15.96 B | |||
| Shares Outstanding | 192.56 M | |||
| Shares Owned By Insiders | 32.76 % | |||
| Shares Owned By Institutions | 36.56 % | |||
| Price To Earning | 21.61 X | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 1.95 X | |||
| Revenue | 6.72 B | |||
| Gross Profit | 1.91 B | |||
| EBITDA | 1.7 B | |||
| Net Income | 782.6 M | |||
| Cash And Equivalents | 718.8 M | |||
| Cash Per Share | 3.74 X | |||
| Total Debt | 2.08 B | |||
| Debt To Equity | 0.70 % | |||
| Current Ratio | 1.33 X | |||
| Book Value Per Share | 24.42 X | |||
| Cash Flow From Operations | 1.51 B | |||
| Earnings Per Share | 3.63 X | |||
| Price To Earnings To Growth | 29.46 X | |||
| Number Of Employees | 61 K | |||
| Beta | 0.63 | |||
| Market Capitalization | 13.82 B | |||
| Total Asset | 9.33 B | |||
| Retained Earnings | 187 M | |||
| Working Capital | 669 M | |||
| Current Asset | 1.49 B | |||
| Current Liabilities | 818 M | |||
| Z Score | 3.6 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 9.33 B | |||
| Last Dividend Paid | 1.0 |
About Eurofins Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eurofins Scientific SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eurofins Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eurofins Scientific SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Eurofins Pink Sheet
Eurofins Scientific financial ratios help investors to determine whether Eurofins Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eurofins with respect to the benefits of owning Eurofins Scientific security.